Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Superficial bladder cancer. Open questions]

A Böhle1

  • 1Klinik für Urologie, Medizinischen Universität zu Lübeck.

Der Urologe. Ausg. A
|November 1, 1994
PubMed
Summary

Research on superficial bladder cancer highlights the need for clinical trials to validate new biological markers and critically analyze current treatments. Further studies are required to optimize recurrence prophylaxis and improve patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 1 Diabetes Mellitus in the First Years of Life - Onset, Initial Treatment, and Early Disease Course.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2024
Same author

[Intravesical gene therapy for patients with BCG-refractory NMIBC?]

Der Urologe. Ausg. A·2021
Same author

[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

Actas urologicas espanolas·2012
Same author

[BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].

Aktuelle Urologie·2009
Same author

[Effect mechanism of intravesical BCG immunotherapy of superficial bladder cancer].

Der Urologe. Ausg. A·2006
Same author

[Study participation in urological specialty practices].

Der Urologe. Ausg. A·2005

Area of Science:

  • Oncology
  • Urology

Context:

  • Superficial bladder cancer presents complex challenges in both basic research and clinical management.
  • Current understanding necessitates further investigation into prognostic markers and treatment efficacy.

Purpose:

  • To identify and discuss critical open questions in the management of superficial bladder cancer.
  • To highlight areas requiring further clinical trials and critical analysis of established procedures.

Summary:

  • The prognostic relevance of novel biological markers requires validation through comparative clinical trials.
  • Established therapeutic procedures for superficial bladder cancer need critical evaluation concerning stage-specific optimal treatment.
  • Recurrence prophylaxis strategies, including therapy of choice, optimal scheduling, and impact on quality of life, remain areas with significant unanswered questions.

Impact:

  • This review aims to guide future research and clinical practice by identifying key areas for investigation.
  • Addressing these open questions is crucial for advancing the treatment and improving outcomes for patients with superficial bladder cancer.

Related Experiment Videos